Fig. 2
From: Frequency and spectrum of PIK3CA somatic mutations in breast cancer
Proportion of PIK3CA mutations in BC in relation to the mutations detected by therascreen. a Proportion of patients with PIK3CA mutations in the combined dataset. b Distribution of the various types of PIK3CA mutations in the combined dataset. c Proportion of PIK3CA mutations detected by the therascreen assay. d Distribution of the various types of PIK3CA mutations detected by the therascreen assay in the combined dataset